Six Spanish-language publications from the U.S. government help patients compare treatments for common illnesses such as heart disease, officials say. The Agency for Healthcare Research and Quality publications summarize the benefits and risks of the medications ACE Inhibitors, or angiotensin-converting enzyme, and ARBs or angiotensin II receptor blockers. The medications help reduce blood pressure in patients who often take other heart-related medications such as aspirin, blood thinners or cholesterol-lowering drugs, officials of the Health and Human Resources' Agency for Healthcare Research and Quality say. "This new Spanish-language guide on heart medications is part of AHRQ's ongoing effort to give Hispanics the knowledge they need to take a greater role in their healthcare," AHRQ Director Dr. Carolyn M. Clancy says in a statement. "All patients should have access to the best information available so they can work with their doctor to identify the best treatment for them." The AHRQ offers 23 publications in Spanish that compare treatments for heart and vascular system conditions, diabetes, cancer, bone and joint-related conditions, pregnancy, mental health and digestive system ailments, Clancy says.
GMT 10:31 2018 Tuesday ,13 November
Russian police uproot 70 underground drug labs in past six monthsGMT 16:32 2018 Tuesday ,06 November
Rwanda aims to achieve universal access to clean water by 2024GMT 16:57 2018 Sunday ,04 November
Palestinian women witness higher cure rate of breast cancerGMT 13:11 2018 Tuesday ,30 October
Emergency surgery saves life of touristGMT 10:44 2018 Tuesday ,23 October
Scientists find microplastics in human stool for first timeGMT 09:18 2018 Tuesday ,23 October
US judge upholds Monsanto weedkiller cancer verdict, reduces payoutGMT 14:22 2018 Friday ,19 October
Birth spacing ‘improving health of Omani women’GMT 15:40 2018 Monday ,15 October
Pakistani president launches nationwide anti-measles driveMaintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2021 ©
Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2021 ©
Send your comments
Your comment as a visitor